Pharmaceutical firms' drug pricing to be scrutinized by Federal Agency of Standards
Hey there! Let's bust some pharma jargon and get to the bone of this issue. The Federal Antimonopoly Service (FAS) is keeping a close eye on the overheated non-JNCLP drug market and ain't mincing words about it. TASS was privy to a conversation where they said this is one of their main focuses at the moment.
Timur Nizhegorodtsev, FAS rep, voiced concerns over the escalating drug costs, with some companies sneakily sticking marketing and other expenses onto the price of these non-JNCLP drugs, causing a price hike.
Come market checks, the FAS will reference the KRAK model of investigation - a pretty juicy case from 2024 when they busted KRAK for violating antimonopoly laws. The company, which was the only supplier of "Ko-Dalnev," hiked prices by 10-16% in 2023, a move that didn't sit well with the FAS. KRAK tried to plead their case in court, but sadly for them, the Moscow Arbitration Court sided with the FAS. The court even ordered KRAK to set a fair price for their drug.
Wanna stay in the know? Follow our Telegram channel @expert_mag for more updates!
Now, here's an interesting tidbit - in jurisdictions like Colorado, they got price gouging laws to protect consumers from insane price hikes during emergencies. So if you're looking for updates on a specific investigation or legal case, it's best to check official statements or press releases from regulatory bodies or legal news sources. After all, no one wants to be gouged!
The Federal Antimonopoly Service (FAS) is focusing on the escalating costs of non-JNCLP drugs in the pharmaceutical market, expressing concerns about hidden marketing and other expenses causing price hikes. This action is reminiscent of their previous investigation into the KRAK model, where they busted the company for violating antimonopoly laws, causing a 10-16% price increase for their drug "Ko-Dalnev." In light of this, it's crucial to follow regulatory bodies or legal news sources for updates on future investigations or legal cases related to medicines and pharmaceuticals.
